Cancer sponge test indigestion: What is the NHS 'sponge test' for cancer and how does the seven-minute capsule test work?
The NHS in England has introduced new guidelines recommending capsule sponge tests for oesophageal cancer detection. This innovative seven-minute test offers a less invasive alternative to traditional endoscopy, tailored for patients with chronic ...

The patient swallows the capsule with water, which dissolves in their stomach releasing the sponge (File)
ALSO READ: Why can't UK football fans watch 3pm Premier League matches live on TV?
What is capsule sponge testing?
According to Cancerresearchuk.org, Capsule sponge testing, sometimes called the ‘pill on a thread’, is a simple test used to help detect oesophageal cancer and its pre-cursor condition, Barrett’s Oesophagus, earlier. It has been tested in clinical trials funded by Cancer Research UK.ALSO READ: Archive of Our Own AO3 website back online at archiveofourown.org
Capsule sponge testing is one approach that could support earlier detection and diagnosis. It works by collecting cells from the lining of the oesophagus, which can then be tested for abnormal changes. The capsule sponge devices most commonly used in the UK are Endosign and Cytosponge. Studies are underway across the UK to understand how this test can be used in different settings to support earlier diagnosis.
How do capsule sponge tests work?
The test kit includes a small capsule containing a compressed sponge attached to a surgical thread. The test is usually carried out by a nurse, taking the following steps:- The patient swallows the capsule with water, which dissolves in their stomach releasing the sponge.
- The sponge is retrieved after a few minutes by gently pulling on the thread.
- As the sponge moves up through the oesophagus, it collects cells from the oesophageal lining
- These cells are sent for analysis for markers of Barrett’s oesophagus or oesophageal cancer
Professor Jonathan Benger, chief executive of National Institute for Health and Care Excellence (Nice), told The Independent: “Oesophageal cancer is very difficult to treat when it is diagnosed at a later stage, so identifying people sooner is really important. “For people with persistent acid reflux and other risk factors, there is an increased chance of developing Barrett’s oesophagus, which can increase their risk of oesophageal cancer.
“Capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett’s oesophagus, helping to identify people who should go on to have further tests and treatment.
“This new technology has the potential to make testing easier for patients, while helping the NHS focus valuable endoscopy capacity on those who need it most.”
Professor Peter Johnson, national clinical director for cancer at NHS England, said: “The NHS is always looking for better ways to get to the bottom of people’s symptoms, and thousands have already benefited from this incredibly efficient test through pilots we have been running, so it’s fantastic it is now being considered for roll-out across the country.
“Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients – reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”
The recommendation is the first to be issued by Nice under the National HealthTech Access Programme. The initiative was designed to identify cutting-edge technology and devices and assess whether they should be used routinely on the health service.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.